Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 994 of 1,261
  1. US 7767672

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted
  2. US 7767677

    Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted
  3. US 7767784

    Methods for preparing polymeric reagents and compositions of polymeric reagents

    Nektar Therapeutics · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted
  4. US 7767717

    Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen

    Northwestern University · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted
  5. US 7767816

    Azaindoles useful as inhibitors of janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted
  6. US 7763590

    Compositions and methods for inhibiting expression of a mutant gene

    Alnylam Pharmaceuticals, Inc. · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted
  7. US 7763637

    Quinolinone-carboxamide compounds as 5-HT4, receptor agonists

    Theravance, Inc. · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted
  8. US 7763719

    Variants of humanized anti-carcinoma MAb CC49

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted
  9. US 7763635

    Once daily dosage forms of trospium

    Supernus Pharmaceuticals, Inc. · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted
  10. US 7763629

    Tetrahydropteridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted
  11. US 7763618

    Pyridyl derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted
  12. US 7763586

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted
  13. US 7763292

    Cancer cell growth inhibition by black bean (Phaseolus vulgaris L) extracts

    INSTITUTO TECNOLÓGICO Y DE ESTUDIOS SUPERIORES DE MONTERREY · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted
  14. US 7763283

    Nitric oxide (NO) releasing material

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted
  15. US 7763259

    Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection

    The Regents of the University of Colorado · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted
  16. US 7763255

    Therapeutic uses of Dunaliella powder

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted
  17. US 7763252

    Methods for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted
  18. US 7763451

    Methods for preparing Bacillus anthracis protective antigen for use in vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted
  19. US 7763716

    Antibody against NPW

    Takeda Pharmaceutical Company Limited · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted
  20. GB 2467012

    Lanthanide (III) ion complexing compounds, luminescent lanthanide (III) ion complexes and use thereof as fluorescent labels

    CIS BIO INT [FR] · Granted Jul 21, 2010 · Expires Jul 16, 2030

    granted
  21. US 7759383

    Small molecule inhibitors of MDM2 and the uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  22. US 7759359

    Method of treating bladder dysfunction with once-a-day trospium salt formulation

    Supernus Pharmaceuticals, Inc. · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  23. US 7759106

    Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (CfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic E. coli

    The United States of America as represented by the Secretary of the Army · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  24. US 7759330

    21-substituted progesterone derivatives as new antiprogestational agents

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.